Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma.

Vos MJ, Tony BN, Hoekstra OS, Postma TJ, Heimans JJ, Hooft L.

Nucl Med Commun. 2007 Jun;28(6):431-9. Review.

PMID:
17460533
2.

Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.

Gómez-Río M, Rodríguez-Fernández A, Ramos-Font C, López-Ramírez E, Llamas-Elvira JM.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):966-75. doi: 10.1007/s00259-007-0661-5. Epub 2008 Jan 3.

PMID:
18172642
3.

Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.

Vos MJ, Hoekstra OS, Barkhof F, Berkhof J, Heimans JJ, van Groeningen CJ, Vandertop WP, Slotman BJ, Postma TJ.

J Clin Oncol. 2003 Oct 1;21(19):3559-65. Epub 2003 Aug 11.

PMID:
12913097
4.

Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.

Matsunaga S, Shuto T, Takase H, Ohtake M, Tomura N, Tanaka T, Sonoda M.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):47-52. doi: 10.1016/j.ijrobp.2012.03.008. Epub 2012 Apr 27.

PMID:
22541963
5.

Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.

Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT.

AJR Am J Roentgenol. 1994 Dec;163(6):1459-65.

PMID:
7992747
6.

A meta-analysis of 99mTc-MIBI SPECT for detection of recurrent glioma after radiation therapy.

Cheng X, Li Y, Xu Z, Li D, Wang J.

J Clin Neurosci. 2011 Mar;18(3):307-12. doi: 10.1016/j.jocn.2010.07.113. Epub 2011 Jan 19.

PMID:
21251837
7.

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.

Cochrane Database Syst Rev. 2015 Sep 29;(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Review.

9.

Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.

Caresia AP, Castell-Conesa J, Negre M, Mestre A, Cuberas G, Mañes A, Maldonado X.

Clin Transl Oncol. 2006 Oct;8(10):750-4.

PMID:
17074674
10.

Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.

Carvalho PA, Schwartz RB, Alexander E 3rd, Garada BM, Zimmerman RE, Loeffler JS, Holman BL.

J Neurosurg. 1992 Oct;77(4):565-70.

PMID:
1527616
11.

Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.

Archer HA, Smailagic N, John C, Holmes RB, Takwoingi Y, Coulthard EJ, Cullum S.

Cochrane Database Syst Rev. 2015 Jun 23;(6):CD010896. doi: 10.1002/14651858.CD010896.pub2. Review.

PMID:
26102272
12.

(201)Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis.

Gómez-Río M, Martínez Del Valle Torres D, Rodríguez-Fernández A, Llamas-Elvira JM, Lozano SO, Font CR, López Ramírez E, Katati M.

Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1237-43. Epub 2004 May 6.

PMID:
15133633
13.

Scintigraphic assessment of recurrent glioma with focus on proliferation.

Alexiou GA, Tsiouris S, Polyzoidis KS, Kyritsis AP, Fotopoulos AD.

Nucl Med Commun. 2008 Sep;29(9):840-1. doi: 10.1097/MNM.0b013e328302ccd6. No abstract available.

PMID:
18677216
14.

Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.

Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shitara N.

Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1201-6.

PMID:
7961030
15.

Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence.

Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP.

Neurol Res. 1994 Apr;16(2):93-6.

PMID:
7914007
16.

Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.

Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, Carvalho PA, Loeffler JS, Shrieve DC, Black PM, Alexander E 3rd.

J Neurosurg. 1998 Jul;89(1):60-8.

PMID:
9647173
17.

201Tl single photon emission tomography in the evaluation of residual and recurrent astrocytoma.

Moustafa HM, Omar WM, Ezzat I, Ziada GA, el-Ghonimy EG.

Nucl Med Commun. 1994 Mar;15(3):140-3.

PMID:
8190401
18.

Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis.

Zhang H, Ma L, Wu C, Xu BN.

J Clin Neurosci. 2015 Feb;22(2):229-37. doi: 10.1016/j.jocn.2014.06.102. Epub 2014 Nov 7.

PMID:
25443083
19.

Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.

Roesdi MF, Postma TJ, Hoekstra OS, van Groeningen CJ, Wolbers JG, Heimans JJ.

J Neurooncol. 1998 Dec;40(3):251-5.

PMID:
10066098
20.

Interobserver variability in the semi-quantitative assessment of 201Tl SPECT in cerebral gliomas.

Tony B, Vos MJ, Berkhof J, Postma TJ, van Lingen A, Heimans JJ, Hoekstra OS.

Nucl Med Commun. 2005 Jan;26(1):45-8.

PMID:
15604947

Supplemental Content

Support Center